Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Oncogene
  • Original Paper
  • Published:

Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activatingβ-catenin/TCF pathway

Oncogenevolume 24, pages6637–6645 (2005)Cite this article

Abstract

Esophageal squamous cell carcinoma (ESCC) has a multifactorial etiology involving environmental and/or genetic factors. End-binding protein 1 (EB1), which was cloned as an interacting partner of the adenomatous polyposis coli (APC) tumor suppressor protein, was previously found overexpressed in ESCC. However, the precise role of EB1 in the development of this malignancy has not yet been elucidated. In this study, we analysed freshly resected ESCC specimens and demonstrated that EB1 was overexpressed in approximately 63% of tumor samples compared to matched normal tissue. We report that overexpression of EB1 in the ESCC line EC9706 significantly promotes cell growth, whereas suppression of EB1 protein level by RNA interference significantly inhibited growth of esophageal tumor cells. In addition, EB1 overexpression induced nuclear accumulation ofβ-catenin and promoted the transcriptional activity ofβ-catenin/T-cell factor (TCF). These effects were partially or completely abolished by coexpression of APC or ΔN TCF4, respectively. Also, we found that EB1 affected the interaction betweenβ-catenin and APC. Furthermore, EB1 overexpression was correlated with cytoplasmic/nuclear accumulation ofβ-catenin in primary human ESCC. Taken together, these results support the novel hypothesis that EB1 overexpression may play a role in the development of ESCC by affecting APC function and activating theβ-catenin/TCF pathway.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 50 print issues and online access

￥40,000 per year

only ￥800 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

￥ 4,980

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Abbreviations

ESCC:

esophageal squamous cell carcinoma

APC:

adenomatous polyposis coli

TCF:

T-cell factor

EC:

esophageal cancer

GSK 3β:

glycogen synthesis kinase 3β

LEF:

leukemia enhancing factor

RT–PCR:

reverse transcription–polymerase chain reaction

TK:

thymidine kinase

HEK:

human embryonal kidney

CGH:

comparative genomic hybridization

NLS:

nuclear localization signals

NES:

nuclear export signals

M-MLV:

mouse-mammary tumor virus

HA:

hemagglutinin

PBS:

phosphate buffered saline

BSA:

bovine serum albumin

IP:

immunoprecipitation

References

  • Berrueta L, Kraeft SK, Tirnauer JS, Schuyler SC, Chen LB, Hill DE, Pellman D and Bierer BE . (1998).Proc. Natl. Acad. Sci. USA,95, 10596–10601.

  • Fodde R, Smits R and Clevers H . (2001).Nat. Rev. Cancer,1, 55–67.

  • Giles RH, van Es JH and Clevers H . (2003).Biochim. Biophys. Acta.,1653, 1–24.

  • Hanahan D and Weinberg RA . (2000).Cell,100, 57–70.

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW . (1998).Science,281, 1509–1512.

  • Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H and Matsumoto K . (1999).Nature,399, 798–802.

  • Louie RK, Bahmanyar S, Siemers KA, Votin V, Chang P, Stearns T, Nelson WJ and Barth AI . (2004).J. Cell Sci.,117, 1117–1128.

  • Parkin DM, Pisani P and Ferlay J . (1999).CA Cancer J. Clin.,49, 33–64.

  • Polakis P . (2000).Genes Dev.,14, 1837–1851.

  • Schena M, Shalon D, Davis RW and Brown PO . (1995).Science,270, 467–470.

  • Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A . (1999).Proc. Natl. Acad. Sci. USA,96, 5522–5527.

  • Stoner GD and Gupta A . (2001).Carcinogenesis,22, 1737–1746.

  • Struski S, Doco-Fenzy M and Cornillet-Lefebvre P . (2002).Cancer Genet. Cytogenet.,135, 63–90.

  • Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B and Kinzler KW . (1995).Cancer Res.,55, 2972–2977.

  • Tirnauer JS and Bierer BE . (2000).J. Cell Biol.,149, 761–766.

  • Uys P and van Helden PD . (2003).Mol. Carcinog.,36, 82–89.

  • Wang YH, Liu S, Zhang G, Zhou CQ, Zhu HX, Zhou XB, Quan LP, Bai JF and Xu NZ . (2005).Breast Cancer Res.,7, R220–R228.

  • Willert J, Epping M, Pollack JR, Brown PO and Nusse R . (2002).BMC Dev. Biol.,2, 8.

  • Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, Fan FS, Chiou TJ, Wang WS and Lin CH . (2001).Cancer,92, 2769–2777.

  • Zhang G, Zhou XB, Xue LY, Quan LP, Wang YH, Yang SB, Yan S, Zhou CQ, Lu N, Zhu HX and Xu NZ . (2005).Pathol. Int.,55, 310–317.

  • Zhou CQ, Liu S, Zhou XB, Xue LY, Quan LP, Lu N, Zhang G, Bai JF, Wang YH, Liu ZH, Zhan Q, Zhu HX and Xu NZ . (2005).Int. J. Cancer,113, 891–898.

  • Zhou J, Liu ZH, Wang XQ, Zhou CN, Zhao J, Zhang RG and Wu M . (1999).Chin. J. Med. Genet.,16, 303–306.

  • Zhou XB, Lu N, Zhang W, Quan LP, Lin DM, Wang QH and Xu NZ . (2002).Aizheng,21, 877–880.

  • Zou XN, Lu FZ, Zhang SW, Sun XD, Huan-Pu XM, Sun J, Zhou YS and Li LD . (2002).Bull. Chin. Cancer,11, 446–449.

Download references

Acknowledgements

We thank Professor Karl Munger for his constructive suggestions and generous help in preparation of the manuscript; Professor B Vogelstein for the APC expression plasmid; Professor ER Fearon for ΔN TCF4 and Professor Mingrong Wang for EC9706 cells. This work was supported by National Natural Science Foundation (39925020, 30271451) and National Basic Research Program (G1998051204, 2004CB518701), PR China.

Author information

Author notes

  1. Xiaobo Zhou

    Present address: Department of Pathology, Harvard Medical School, Boston, USA

  2. Yihua Wang and Xiaobo Zhou: These authors contributed equally to this work

Authors and Affiliations

  1. Laboratory of Cell and Molecular Biology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, PR China

    Yihua Wang, Xiaobo Zhou, Hongxia Zhu, Shuang Liu, Cuiqi Zhou, Guo Zhang, Lanping Quan, Jinfeng Bai & Ningzhi Xu

  2. Department of Pathology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China

    Liyan Xue & Ning Lu

  3. National Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China

    Qimin Zhan

Authors
  1. Yihua Wang
  2. Xiaobo Zhou
  3. Hongxia Zhu
  4. Shuang Liu
  5. Cuiqi Zhou
  6. Guo Zhang
  7. Liyan Xue
  8. Ning Lu
  9. Lanping Quan
  10. Jinfeng Bai
  11. Qimin Zhan
  12. Ningzhi Xu

Corresponding author

Correspondence toNingzhi Xu.

Rights and permissions

About this article

Cite this article

Wang, Y., Zhou, X., Zhu, H.et al. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activatingβ-catenin/TCF pathway.Oncogene24, 6637–6645 (2005). https://doi.org/10.1038/sj.onc.1208819

Download citation

Keywords

This article is cited by

Access through your institution
Buy or subscribe

Advertisement

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2026 Movatter.jp